Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
These authors contributed equally to the manuscript.
Euro Surveill. 2021 Apr;26(15). doi: 10.2807/1560-7917.ES.2021.26.15.1900760.
IntroductionIn contrast to countries where carbapenemase-producing Enterobacterales (CPE) are endemic, only sporadic cases were reported in Switzerland until 2013. An aggravation of the epidemiological situation in neighbouring European countries indicated the need for a surveillance study in Switzerland.AimWe aimed to describe CPE distributions in Switzerland and identify epidemiological factors associated with changes in incidence.MethodsData on all human CPE isolates from 2013 to 2018 were collected by the Swiss Centre for Antibiotic Resistance (ANRESIS) and analysed for temporal and regional trends by Generalised Poisson regression. Isolates associated with infection or colonisation were included in a primary analysis; a secondary analysis included invasive isolates only. Statistical detection of regional clusters was performed with WHONET/SaTScan.ResultsWe analysed 731 CPE isolates, of which 325 (44.5%) were associated with screenings and 173 (23.7%) with infections. Yearly detection of CPE isolates increased considerably during the study period from 65 to 212. The most frequently isolated species were (54%) and (28%). The most frequent genotypes were OXA-48 (43%), KPC (21%) and NDM (14%). In contrast to the French-speaking parts of Switzerland (West, Geneva) where OXA-48 were the predominant genotypes (around 60%), KPC was the most frequently detected genotype in the Italian-speaking region (63%). WHONET/SaTScan outbreak detection analysis identified seven clusters in five regions of Switzerland.ConclusionsIn a first continuous surveillance of CPE in Switzerland, we found that the epidemiological situation aggravated nationwide and that regional patterns of CPE genotypes mirrored the situation in neighbouring European countries.
引言
与碳青霉烯酶肠杆菌科(CPE)流行的国家相比,2013 年之前瑞士仅报告了散发病例。邻国欧洲国家的流行病学情况恶化表明,瑞士需要进行监测研究。
目的
我们旨在描述瑞士的 CPE 分布,并确定与发病率变化相关的流行病学因素。
方法
瑞士抗生素耐药性监测中心(ANRESIS)收集了 2013 年至 2018 年所有人类 CPE 分离株的数据,并通过广义泊松回归分析了时间和地区趋势。将与感染或定植相关的分离株纳入主要分析;次要分析仅包括侵袭性分离株。使用 WHONET/SaTScan 进行区域聚类的统计检测。
结果
我们分析了 731 株 CPE 分离株,其中 325 株(44.5%)与筛查有关,173 株(23.7%)与感染有关。在研究期间,每年检测到的 CPE 分离株数量从 65 株显著增加到 212 株。最常分离到的物种是 (54%)和 (28%)。最常见的基因型是 OXA-48(43%)、KPC(21%)和 NDM(14%)。与瑞士法语区(西部、日内瓦)以 OXA-48 为主导基因型(约 60%)的情况相反,意大利语区最常检测到的基因型是 KPC(63%)。WHONET/SaTScan 爆发检测分析在瑞士五个地区发现了七个集群。
结论
在瑞士首次对 CPE 进行连续监测中,我们发现全国范围内的流行病学情况恶化,CPE 基因型的地区模式反映了邻国欧洲国家的情况。